Improving chondrogenesis: Potential and limitations of sox9 gene transfer and mechanical stimulation for cartilage tissue engineering

Tissue Engineering - Part A

Volumn 16, Issue 6, 2010, Pages 1845-1855

  Kupcsik, Laszlo ^a,b   Stoddart, Martin J ^a   Li, Zhen ^a,c   Benneker, Lorin M ^d   Alini, Mauro ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c ZHEJIANG UNIVERSITY   (China)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CARTILAGE; CELL CULTURE; COMPLEXATION; GENE TRANSFER; LIGAMENTS; PELLETIZING; PEPTIDES; THREE DIMENSIONAL; TISSUE ENGINEERING; TRANSCRIPTION; TRANSCRIPTION FACTORS;

ADDITIONAL TREATMENT; ADENOVIRAL VECTORS; ARTICULAR CARTILAGES; CARTILAGE TISSUE ENGINEERING; CHONDROCYTES; CHONDROGENESIS; COFACTORS; DEVELOPED COUNTRIES; DEXAMETHASONES; EXOGENOUS GROWTH; EXPRESSION LEVELS; HUMAN MESENCHYMAL STEM CELLS; HYDROGEL SCAFFOLDS; KNOWN TARGET GENES; LUBRICIN; MATRIX PROTEINS; MECHANICAL LOADS; MECHANICAL STIMULATION; MECHANOTRANSDUCTION; MESENCHYMAL STEM CELL; PRODUCTION RATES; STEM CELL THERAPY; SULFATED GLYCOSAMINOGLYCANS; THREE-DIMENSIONAL (3D); TRANSFORMING GROWTH FACTORS;

STEM CELLS;

ADENOVIRIDAE;

AGGRECAN; GLYCOSAMINOGLYCAN; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BIOREACTOR; CARTILAGE; CELL CULTURE; CHONDROGENESIS; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HUMAN; HYDROGEL; IMMUNOHISTOCHEMISTRY; MECHANICAL STRESS; MESENCHYMAL STEM CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

AGGRECANS; BIOREACTORS; CARTILAGE; CELLS, CULTURED; CHONDROGENESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOSAMINOGLYCANS; HUMANS; HYDROGELS; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELLS; POLYMERASE CHAIN REACTION; SOX9 TRANSCRIPTION FACTOR; STRESS, MECHANICAL; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77953351772     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0531     Document Type: Article

References (49)

1. Clar, C., Cummins, E., McIntyre, L., Thomas, S., Lamb, J., Bain, L., Jobanputra, P., and Waugh, N. Clinical and cost-effectiveness of autologous chondrocyte implantation for cartilage defects in knee joints: systematic review and economic evaluation. Health Technol Assess 9, iii, 2005.
2. Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O., and Peterson, L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med 331, 889, 1994.
3. Hangody, L., Kish, G., Karpati, Z., Udvarhelyi, I., Szigeti, I., and Bely, M. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. Orthopedics 21, 751, 1998.
4. Ficat, R.P., Ficat, C., Gedeon, P., and Toussaint, J.B. Spon-gialization: a new treatment for diseased patellae. Clin Or-thop Relat Res 144, 74, 1979.
5. Steadman, J.R., Rodkey, W.G., and Rodrigo, J.J. Micro-fracture: surgical technique and rehabilitation to treat chon-dral defects. Clin Orthop Relat Res 391 Suppl, S362, 2001.
6. Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M., and Yoo, J.U. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238, 265, 1998.
7. Yoo, J.U., Barthel, T.S., Nishimura, K., Solchaga, L., Caplan, A.I., Goldberg, V.M., and Johnstone, B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80, 1745, 1998.
8. Zhou, G., Lefebvre, V., Zhang, Z., Eberspaecher, H., and de Crombrugghe, B. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo. J Biol Chem 273, 14989, 1998.
9. Han, Y., and Lefebvre, V. L-Sox5 and Sox6 drive expression of the aggrecan gene in cartilage by securing binding of Sox9 to a far-upstream enhancer. Mol Cell Biol 28, 4999, 2008.
10. Ikeda, T., Kamekura, S., Mabuchi, A., Kou, I., Seki, S., Takato, T., Nakamura, K., Kawaguchi, H., Ikegawa, S., and Chung, U.i. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum 50, 3561, 2004.
11. Takahashi, I., Nuckolls, G.H., Takahashi, K., Tanaka, O., Semba, I., Dashner, R., Shum, L., and Slavkin, H.C. Com-pressive force promotes sox9, type II collagen and aggrecan and inhibits IL-1beta expression resulting in chondrogenesis in mouse embryonic limb bud mesenchymal cells. J Cell Sci 111 (Pt 14), 2067, 1998.
12. Grad, S., Lee, C.R., Gorna, K., Gogolewski, S., Wimmer, M.A., and Alini, M. Surface motion upregulates superficial zone protein and hyaluronan production in chondrocyte-seeded three-dimensional scaffolds. Tissue Eng 11, 249, 2005.
13. Elder, S.H., Goldstein, S.A., Kimura, J.H., Soslowsky, L.J., and Spengler, D.M. Chondrocyte differentiation is modulated by frequency and duration of cyclic compressive loading. Ann Biomed Eng 29, 476, 2001.
14. Angele, P., Schumann, D., Angele, M., Kinner, B., Englert, C., Hente, R., Fuchtmeier, B., Nerlich, M., Neumann, C., and Kujat, R. Cyclic, mechanical compression enhances chon-drogenesis of mesenchymal progenitor cells in tissue engineering scaffolds. Biorheology 41, 335, 2004.
15. Mouw, J.K., Connelly, J.T., Wilson, C.G., Michael, K.E., and Levenston, M.E. Dynamic compression regulates the expression and synthesis of chondrocyte-specific matrix molecules in bone marrow stromal cells. Stem Cells 25, 655, 2007.
16. Li, Z., Kupcsik, L., Yao, S.J., Alini, M., and Stoddart, M.J. Mechanical load modulates chondrogenesis of human mes-enchymal stem cells through the TGF-beta pathway. J Cell Mol Med 2009. [Epub ahead of print]. DOI: 10.1111=j.1582-4934.2009.00780.x
17. Terraciano, V., Hwang, N., Moroni, L., Park, H.B., Zhang, Z., Mizrahi, J., Seliktar, D., and Elisseeff, J. Differential response of adult and embryonic mesenchymal progenitor cells to mechanical compression in hydrogels. Stem Cells 25, 2730, 2007.
18. Li, Z., Kupcsik, L., Yao, S., Alini, M., and Stoddart, M.J. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites. Tissue Eng A 15, 1729, 2009.
19. Wimmer, M.A., Grad, S., Kaup, T., Hänni, M., Schneider, E., Gogolewski, S., and Alini, M. Tribology approach to the engineering and study of articular cartilage. Tissue Eng 10, 1436, 2004.
20. Solchaga, L.A., Welter, J.F., Lennin, D.P., and Caplan, A.I. Generation of Pluripotent stem cells and their differentiation to the chondrocytic phenotype. In: Sabatini, M., Pastoureau, P., De Ceuninck, F., eds. Cartilage and osteoarthritis. Toto-wa, NJ: Humana Press, 2004, p. 53.
21. Hardy, S., Kitamura, M., Harris-Stansil, T., Dai, Y., and Phipps, M.L. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71, 1842, 1997.
22. Paul, R., Haydon, R.C., Cheng, H., Ishikawa, A., Nenadovich, N., Jiang, W., Zhou, L., Breyer, B., Feng, T., Gupta, P., He, T.C., and Phillips, F.M. Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine 28, 755, 2003.
23. Palmer, G.D., Stoddart, M.J., Gouze, E., Gouze, J.N., Ghivizzani, S.C., Porter, R.M., and Evans, C.H. A simple, lanthanide-based method to enhance the transduction efficiency of adenovirus vectors. Gene Ther 15, 357, 2008.
24. Grad, S., Kupcsik, L., Gorna, K.I., Gogolewski, S., and Alini, M. The use of biodegradable polyurethane scaffolds for cartilage tissue engineering: potential and limitations. Bio-materials 28, 5163.
25. Lee, C.R., Grad, S., Gorna, K., Gogolewski, S., Goessl, A., and Alini, M. Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. Tissue Eng 11, 1562, 2005.
26. Kupcsik, L., Alini, M., and Stoddart, M.J. Epsilon-aminocaproic acid is a useful fibrin degradation inhibitor for cartilage tissue engineering. Tissue Eng A 8, 2304, 2009.
27. Labarca, C., and Paigen, K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102, 344, 1980.
28. Farndale, R.W., Buttle, D.J., and Barrett, A.J. Improved quantitation and discrimination of sulphated glycosamino-glycans by use of dimethylmethylene blue. Biochim Biophys Acta 883, 173, 1986.
29. Lee, C.R., Grad, S., Maclean, J.J., Iatridis, J.C., and Alini, M. Effect of mechanical loading on mRNA levels of common endogenous controls in articular chondrocytes and inter-vertebral disk. Anal Biochem 341, 372, 2005.
30. Barta, E., Sebestyén, E., Pálfy, T.B., Tóth, G., Ortutay, C.P., and Patthy, L. DoOP: databases of orthologous promoters, collections of clusters of orthologous upstream sequences from chordates and plants. Nucleic Acids Res 33, D86, 2005.
31. Core Team, RD, Core Team, RDCore Team,RD R:A language and environment for statistical computing R: A language and environment for statistical computing Core Team, RD2005 Vienna, AustriaR Foundation for Statistical Computing.
32. Miyanishi, K., Trindade, M.C., Lindsey, D.P., Beaupre, G.S., Carter, D.R., Goodman, S.B., Schurman, D.J., and Smith, R.L. Dose-and time-dependent effects of cyclic hydrostatic pressure on transforming growth factor-beta3-induced chondrogenesis by adult human mesenchymal stem cells in vitro. Tissue Eng 12, 2253, 2006.
33. Li, Z., Yao, S.J., Alini, M., and Stoddart, M.J. Chondrogenesis of human bone marrow mesenchymal stem cells in fibrin-polyurethane composites is modulated by frequency and amplitude of dynamic compression and shear stress. Tissue Eng A 16, 575, 2010.
34. Mukherjee, N., Saris, D.B., Schultz, F.M., Berglund, L.J., An, K.N., and O' Driscoll, S.W. The enhancement of periosteal chondrogenesis in organ culture by dynamic fluid pressure. J Orthop Res 19, 524, 2001.
35. Smith, R.K., Zunino, L., Webbon, P.M., and Heinega?rd, D. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 16, 255, 1997.
36. Grad, S., Gogolewski, S., Alini, M., and Wimmer, M.A. Effects of simple and complex motion patterns on gene expression of chondrocytes seeded in 3D scaffolds. Tissue Eng 12, 3171, 2006.
37. Kipnes, J., Carlberg, A.L., Loredo, G.A., Lawler, J., Tuan, R.S., and Hall, D.J. Effect of cartilage oligomeric matrix protein on mesenchymal chondrogenesis in vitro. Osteoar-thritis Cartilage 11, 442, 2003.
38. Mwale, F., Stachura, D., Roughley, P., and Antoniou, J. Limitations of using aggrecan and type X collagen as markers of chondrogenesis in mesenchymal stem cell differentiation. J Orthop Res 24, 1791, 2006.
39. Neu, C.P., Khalafi, A., Komvopoulos, K., Schmid, T.M., and Reddi, A.H. Mechanotransduction of bovine articular cartilage superficial zone protein by transforming growth factor beta signaling. Arthritis Rheum 56, 3706, 2007.
40. Barry, F., Boynton, R.E., Liu, B., and Murphy, J.M. Chon-drogenic differentiation of mesenchymal stem cells from bone marrow: differentiation- dependent gene expression of matrix components. Exp Cell Res 268, 189, 2001.
41. Kisiday, J.D., Kopesky, P.W., Evans, C.H., Grodzinsky, A.J., McIlwraith, C.W., and Frisbie, D.D. Evaluation of adult equine bone marrow-and adipose-derived progenitor cell chondrogenesisinhydrogel cultures.J Orthop Res 3,322, 2008.
42. Gouze, J.N., Bordji, K., Gulberti, S., Terlain, B., Netter, P., Magdalou, J., Fournel-Gigleux, S., and Ouzzine, M. Interleukin-1beta down-regulates the expression of glucur-onosyltransferase I, a key enzyme priming glycosamino-glycan biosynthesis: influence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum 44, 351, 2001.
43. Gouze, J.N., Gouze, E., Popp, M.P., Bush, M.L., Dacanay, E.A., Kay, J.D., Levings, P.P., Patel, K.R., Saran, J.P., Watson, R.S., and Ghivizzani, S.C. Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta. Arthritis Res Ther 8, R173, 2006.
44. Cucchiarini, M., Thurn, T., Weimer, A., Kohn, D., Terwilli-ger, E.F., and Madry, H. Restoration of the extracellular matrix in human osteoarthritic articular cartilage by over-expression of the transcription factor SOX9. Arthritis Rheum 56, 158, 2007.
45. Tew, S.R., Li, Y., Pothacharoen, P., Tweats, L.M., Hawkins, R.E., and Hardingham, T.E. Retroviral transduction with SOX9 enhances re-expression of the chondrocyte phenotype in passaged osteoarthritic human articular chondrocytes. Osteoarthritis Cartilage 13, 80, 2005.
46. Lefebvre, V., Li, P., and de Crombrugghe, B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J 17, 5718, 1998.
47. Bridgewater, L.C., Lefebvre, V., and de Crombrugghe, B. Chondrocyte-specific enhancer elements in the Col11a2 gene resemble the Col2a1 tissue-specific enhancer. J Biol Chem 273, 14998, 1998.
48. Genzer, M.A., and Bridgewater, L.C. A Col9a1 enhancer element activated by two interdependent SOX9 dimers. Nucleic Acids Res 35, 1178, 2007.
49. Liu, C.J., Zhang, Y., Xu, K., Parsons, D., Alfonso, D., and Di Cesare, P.E. Transcriptional activation of cartilage oligo-meric matrix protein by Sox9, Sox5, and Sox6 transcription factors and CBP=p300 coactivators. Front Biosci 12, 3899, 2007.